Series A funding round for Lusaris Therapeutics raising $60M in November 2022
Series A funding round for Lusaris Therapeutics raising $60M in November 2022
| Investor | Firm Type | Partner |
|---|
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$60M
Top Valuation
-
Lusaris Therapeutics raised $60M in a Series A round.
The round was announced on 11/01/22.
The round was led by Andrew Levin.